Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03241186
Title Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Robert R. McWilliams, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic- Florida Jacksonville Florida 32224 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
University of Minnesota Minneapolis Minnesota 555455455 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field